- Home
- ULH vs PROK Comparison
ULH vs PROK Comparison
Compare ULH & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ULH | PROK |
|---|---|---|
| Founded | 1932 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.0M | 417.1M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ULH | PROK |
|---|---|---|
| Price | $17.04 | $2.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $17.00 | $7.40 |
| AVG Volume (30 Days) | 61.4K | ★ 1.3M |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,638,101,000.00 | $744,000.00 |
| Revenue This Year | N/A | $956.51 |
| Revenue Next Year | $3.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.78 | $0.46 |
| 52 Week High | $47.42 | $7.13 |
Technical Indicators
Market Signals| Indicator | ULH | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 50.68 |
| Support Level | $15.79 | $2.10 |
| Resistance Level | $17.39 | $2.54 |
| Average True Range (ATR) | 0.97 | 0.16 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 84.17 | 53.61 |
Price Performance
Historical ComparisonAbout ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.